TGFβ1/Smad3 counteracts BRCA1-dependent repair of DNA damage

Oncogene

Volumn 24, Issue 14, 2005, Pages 2289-2297

  Dubrovska, Anna ^a   Kanamoto, Takashi ^a,b   Lomnytska, Marta ^a,c   Heldin, Carl Henrik ^a   Volodko, Natalya ^c   Souchelnytskyi, Serhiy ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b HIROSHIMA UNIVERSITY   (Japan)

^c DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

BRCA1; Breast cancer; DNA repair; Smad3; Transforming growth factor

Indexed keywords

BRCA1 PROTEIN; DOUBLE STRANDED DNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; DNA BINDING PROTEIN; SMAD3 PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER INVASION; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FAMILIAL CANCER; GEL ELECTROPHORESIS; GENE INACTIVATION; GENE REPRESSION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; CELL LINE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; GENES, BRCA1; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 16444384985     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208443     Document Type: Article

References (30)

1. Boulay J-L, Mild G, Lowly AJ, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R and Rochlitz C. (2002). Br. J. Cancer, 87, 630-634.
2. de Caestecker M, Piek E and Roberts AB. (2000). J. Natl. Cancer Inst., 92, 1388-1402.
3. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier JM. (1998). EMBO J., 17, 3091-3100.
4. Derynck R, Akhurst RJ and Balmain A. (2001). Nat. Genet., 29, 117-129.
5. Derynck R and Zhang YE. (2003). Nature, 425, 577-584.
6. Ewan KB, Henshall-Powel RL, Ravani SA, Pajares MJ, Arteaga C, Warters R, Akhurst RJ and Barcellos-Hoff MH. (2002). Cancer Res., 62, 5627-5631.
7. Glick A, Popescu N, Alexander V, Ueno H, Botinger E and Yuspa SH. (1999). Proc. Natl. Acad. Sci. USA, 96, 4949-14954.
8. Kanamoto T, Hellman U, Heldin C-H and Souchelnytskyi S. (2002). EMBO J., 21, 1219-1230.
9. Kinzler KW and Vogelstein B. (1997). Nature, 386, 761-763.
10. Kretzschmar M, Doody J, Timokhina I and Massagué J. (1999). Genes Dev., 13, 804-816.
11. Lomnytska M, Lukiyanchuk V, Hellman U and Souchelnytskyi S. (2004). Proteomics, 4, 995-1006.
12. Miyajima A, Asano T, Seta K, Asano T, Kakoi N and Hayakawa M. (2003). Urology, 61, 1072-1077.
13. Mulder KM. (2000). Cytokine Growth Factor Rev., 11, 23-35.
14. Muray PA, Barrett-Lee P, Travers M, Luqmani Y, Powles T and Coombes RC. (1993). Br. J. Cancer, 67, 1408-1412.
15. Ouchi T, Monteiro ANA, August A, Aaronson SA and Hanafusa H. (1998). Proc. Natl. Acad. Sci. USA, 95, 2302-2306.
16. Paull TT, Cortez D, Bowers B, Elledge SJ and Gellert M. (2001). Proc. Natl. Acad. Sci. USA, 98, 6086-6091.
17. Preobrazhenska O, Yakymovych M, Kanamoto T, Yakymovych I, Stoika R, Heldin C-H and Souchelnytskyi S. (2002). Oncogens, 21, 5660-5664.
18. Pulaski L, Landström M, Heldin C-H and Souchelnytskyi S. (2001). J. Biol. Chem., 276, 14344-14349.
19. Schmied BM, Ulrich AB, Matsuzaki H, El-Metwally TH, Ding X, Fernandes ME, Adrian TE, Chaney WG, Batra SK and Pour PM. (2000). Carcinogenesis, 21, 1121-1127.
20. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM. (1997). Cell, 88, 265-275.
21. Siegel PM and Massague J. (2003). Nature Rev., 3, 807-820.
22. Souchelnytskyi S. (2002). Exp. Oncol., 24, 3-12.
23. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF and Taketo MM. (1998). Cell, 92, 645-656.
24. Venkitaraman AR. (2002). Cell, 108, 171-182.
25. Wang Q, Zhang H, Fishel R and Greene MI. (2000). Oncogene, 19, 6152-6158.
26. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB and Hamilton SR. (2001). New Engl. J. Med., 344, 1196-1206.
27. Xiangming C, Natsugoe S, Takao S, Hokita S, Ishigami S, Tanabe G, Baba M, Kuroshima K and Aikou T. (2001). Clin. Cancer Res., 7, 277-282.
28. Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG and Reiss M. (2002). Cancer Res., 62, 497-505.
29. Yakymovych I, ten Dijke P, Heldin C-H and Souchelnytskyi S. (2001). FASEB J., 15, 553-556.
30. Zhu Y, Richardson JA, Parada LF and Graff J. (1998). Cell, 94, 703-714.